PDT Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,216
Closed -$543K 619
2025
Q2
$543K Buy
10,216
+11
+0.1% +$559 0.03% 514
2025
Q1
$442K Sell
10,205
-21
-0.2% -$1.06K 0.03% 547
2024
Q4
$575K Sell
10,226
-34,584
-77% -$2.15M 0.05% 448
2024
Q3
$3.05M Buy
+44,810
New +$2.53M 0.27% 113
2023
Q4
Sell
-55,060
Closed -$3.76M 576
2023
Q3
$3.76M Buy
55,060
+11,743
+27% +$996K 0.47% 41
2023
Q2
$4.07M Buy
+43,317
New +$3.38M 0.56% 32
2021
Q4
Sell
-9,900
Closed -$945K 912
2021
Q3
$945K Buy
+9,900
New +$1.05M 0.07% 359
2020
Q4
Sell
-3,620
Closed -$369K 734
2020
Q3
$369K Sell
3,620
-1,387
-28% -$120K 0.02% 508
2020
Q2
$435K Buy
+5,007
New +$400K 0.03% 446
2020
Q1
Sell
-34,294
Closed -$3.17M 719
2019
Q4
$3.17M Sell
34,294
-49,206
-59% -$4.33M 0.2% 147
2019
Q3
$7.55M Hold
83,500
0.45% 89
2019
Q2
$9.86M Sell
83,500
-41,800
-33% -$4.21M 0.58% 48
2019
Q1
$10.9M Sell
125,300
-30,500
-20% -$2.6M 0.61% 35
2018
Q4
$9.83M Sell
155,800
-1
-0% -$69 0.55% 47
2018
Q3
$12.3M Buy
155,801
+41,501
+36% +$2.71M 0.51% 51
2018
Q2
$6.83M Buy
+114,300
New +$6.15M 0.26% 130
2016
Q4
Sell
-397,500
Closed -$7.38M 517
2016
Q3
$7.38M Buy
397,500
+167,900
+73% +$2.96M 0.43% 100
2016
Q2
$2.81M Hold
229,600
0.22% 170
2016
Q1
$1.55M Hold
229,600
0.1% 260
2015
Q4
$2.12M Buy
+229,600
New +$2.13M 0.29% 146
2014
Q2
Sell
-20,064
Closed -$284K 1464
2014
Q1
$284K Buy
+20,064
New +$271K 0.01% 1131
2013
Q3
Sell
-173,390
Closed -$2.41M 1561
2013
Q2
$2.41M Buy
+173,390
New +$1.88M 0.06% 461

Other funds holding EXAS

PDT Partners's EXAS Position: Q3 2025 in Review

PDT Partners sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 10,216 shares — an estimated $543K sold.

PDT Partners first reported a position in EXAS in Q2 2013 and held it in 22 quarters. The position peaked at $12.3M in Q3 2018. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • PDT Partners reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • PDT Partners sold 10,216 Exact Sciences shares in Q3 2025, an estimated $543K.
  • PDT Partners first reported a position in Exact Sciences in Q2 2013 and held it in 22 quarters.
  • PDT Partners's Exact Sciences position peaked at $12.3M in Q3 2018.
  • 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.